Hims & Hers Health (HIMS) return on equity (ROE)

Return on equity · fiscal 2025
23.7%

Hims & Hers Health (HIMS) earned a return on equity of 23.7% in fiscal 2025 (the year ended December 31, 2025). That is 2.7 percentage points lower than the 26.4% of fiscal 2024. Figures as of 17 Nov 2026, 22:30 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
23.7%
Change on fiscal 2024
−2.7 pts
Highest on record
26.4%fiscal 2024
Lowest on record
-32.2%fiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Hims & Hers Health return on equity (ROE), in more detail

Across the 5 fiscal years on record (2021–2025), the highest was 26.4% in fiscal 2024 and the lowest -32.2% in fiscal 2021. The fiscal 2025 figure is higher than in 75% of the 4 earlier fiscal years on record, whose median is -14.0%.

History · 5 fiscal years

Return on equity by fiscal year

Hims & Hers Health return on equity (ROE), year by year

Hims & Hers Health (HIMS) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202523.7% 2.7 pts down
202426.4% 33.3 pts up
2023-6.8% 14.2 pts up
2022-21.1% 11.1 pts up
2021-32.2%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Hims & Hers Health and comparable companies
CompanyReturn on equityFiscal year
BillionToOne BLLN1.6%2025
Hims & Hers Health HIMS23.7%2025
PTC Therapeutics PTCT-36432.6%2021
Haemonetics HAE12.2%2026
Erasca ERAS-38.3%2025
Concentra Group Holdings Parent CON42.3%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on HIMS

Hims & Hers Health, figure by figure

Hims & Hers Health (HIMS) overview: price, valuation and scorecardAll health care companies by market value

Hims & Hers Health return on equity (ROE): questions and answers

What is Hims & Hers Health's return on equity?

Hims & Hers Health (HIMS) earned a return on equity of 23.7% in fiscal 2025 (the year ended December 31, 2025). That is 2.7 percentage points lower than the 26.4% of fiscal 2024.

Is Hims & Hers Health's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 75% of the 4 earlier fiscal years on record, whose median is -14.0%.

What are the highest and lowest return on equity figures on record for Hims & Hers Health?

Across the 5 fiscal years on record (2021–2025), the highest was 26.4% in fiscal 2024 and the lowest -32.2% in fiscal 2021.

How is Hims & Hers Health's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Hims & Hers Health (HIMS) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/HIMS/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.